Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Scholar Rock Holding (2QK) Drug Pipeline

2 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Apitegromab, Srk-015Fshd, Facioscapulohumeral Muscular DystrophyPhase IINot Yet RecruitingPhase 2 Study Evaluating Apitegromab for the Treatment of FSHDFeb 10, 2026―
Nusinersen, Apitegromab, RisdiplamSpinal Muscular Atrophy Type 3, Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 2, Sma, Neuromuscular Manifestations, Anti-MyostatinPhase IIRecruitingA Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular AtrophyApr 16, 2025
Tirzepatide, ApitegromabOverweight And ObesityPhase IICompletedEfficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or ObeseMay 22, 2024―
ApitegromabAtrophy, Muscular Atrophy, Spinal, Muscular Atrophy, Neuromuscular Diseases, Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Anti-Myostatin, Neuromuscular Manifestations, Sma, Spinal Muscular Atrophy Type 2Phase IIIActive Not RecruitingLong-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of ApitegromabNov 07, 2022―
ApitegromabSpinal Muscular Atrophy Type 2, Spinal Muscular Atrophy, Sma, Neuromuscular Manifestations, Anti-Myostatin, Spinal Muscular Atrophy Type 3, Muscular Atrophy, Neuromuscular Diseases, Atrophy, Muscular Atrophy, SpinalPhase IIICompletedEfficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or RisdiplamDec 01, 2021―
Srk-181, Anti-Pd-1 Antibody TherapyCancerPhase ICompletedSRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)Feb 25, 2020―
Srk-015Sma, Neuromuscular Manifestations, Muscular Atrophy, Spinal, Atrophy, Neuromuscular Diseases, Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 2, Spinal Muscular AtrophyPhase IICompletedAn Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular AtrophyApr 16, 2019―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Scholar Rock Holding (DE:2QK) have in its pipeline
Scholar Rock Holding DE:2QK is currently developing the following drugs: Apitegromab, Srk-015, Nusinersen, Apitegromab, Risdiplam, Tirzepatide, Apitegromab, Apitegromab, Srk-181, Anti-Pd-1 Antibody Therapy, Srk-015. These drug candidates are in various stages of clinical development as the company works toward FDA approval.